Renalytix plc (RNLX) Stock Price, News & Analysis
Company Description
Renalytix plc (NASDAQ: RNLX) is classified in the diagnostic imaging centers industry within the Services-medical Laboratories sector and carries a market capitalization of $17.2M, ranking #6,393 among all listed U.S. companies by market cap.
RNLX has declined 83.2% over the past year. Shares last traded at $0.2071.
This page collects what Stock Titan holds for RNLX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Renalytix plc (RNLX) stock last closed at $0.2071. Over the past 12 months, the stock has lost 83.2%. At a market capitalization of $17.2M, RNLX is classified as a micro-cap stock.
RNLX Rankings
Latest News
Renalytix plc has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, conferences. View all RNLX news →
SEC Filings
Renalytix plc has filed 3 recent SEC filings, including 2 Form S-8 POS, 1 Form 15-12G. The most recent filing was submitted on July 30, 2025. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all RNLX SEC filings →
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RNLX Company Profile & Sector Positioning
Renalytix plc (RNLX) operates in the Diagnostic Imaging Centers industry within the broader Services-medical Laboratories sector and is listed on the NASDAQ.